JTNews | October 13, 2013

Download JTNews | October 13, 2013

Post on 14-Apr-2018




0 download

Embed Size (px)


  • 7/27/2019 JTNews | October 13, 2013


    o c t o b e r 1 1 , 2 0 1 3 n 7 c h e s h v a n 5 7 7 4 n v o l u m e 8 9 , n o . 2 1 n w w w . j t n e w s . n ecourtesy nyh

    retired? hows your portfolio?page 25

    meet anne frankpage 10

    high school programs expandpage 6

    t h e v o i c e o f

    w a s h i n g t o n


    yv b .s j-t 14

    Al hands on deck!



  • 7/27/2019 JTNews | October 13, 2013


    2 israel: to your health Jtn nwww.Jtnews.net n friday, october 11, 201







    Join the Holocaust CenterThursday, October 31st

    The Westin Seattle11:30 a.m. - 1:30 p.m.

    The Holocaust Center proudly presents

    the Voices for Humanity Award to

    Laurie Warshal Cohen and Mike Cohenfor their dedication to the Holocaust Center,

    and to Comcast for their

    extaordinary commitment to the Centers work.

    Verizon Keynote Speaker

    Mark Weitzman, Government Affairs Director

    The Simon Weisenthal Center

    Fighting Hate in the International Arena


    Oh, th nrv! Gint lps in rpiring body dmg

    Janis siegel Jtnw columiMillions who suer rom

    nerve damage and even paral-

    ysis may soon be able to take

    a heretoore impossible giant

    leap orward aer the results

    o two successul el AvivUniversity studies one

    using a gel inside a biode-

    gradable nerve wall implant,

    and the second that injected

    a newly discovered protein

    compound in animal sub-

    jects that provided substantial

    healing results.

    While medical discov-

    eries bring us ever closer to regenerat-

    ing organs such as the liver and even the

    heart muscle, the nervous system, whose

    damage leaves many people with perma-

    nent pain, loss o movement, and paraly-

    sis, remains uncured.

    Earlier this year, a team headed by

    Pro. Zvi Nevo and Dr. Shimon Rochkind

    rom el Aviv University created the gel-

    implant therapy that regenerated periph-

    eral nerves.

    Although the doctors say that the pro-

    cedure is still a ew years away rom use in

    a clinical setting, the gel, called Guiding

    Regeneration Gel, promotes nerve growth

    and was also ound to potentially restore

    unction to a damaged or torn nerve, with

    or without the use o the bio-

    degradable implant.

    Te gel by itsel can be

    used as a stand-alone prod-

    uct, acting as an aid to cell

    therapy, said Rochkind in aAU interview. GRG is not

    only able to preserve cells,

    it can support their survival

    while being used or therapy

    and transplantation.

    Every day, our bodies use

    a vast nerve network set in

    motion by electrical signals

    within our body. Peripheral

    nerves transmit signals rom the spinal

    cord out to the rest o the body and they

    also reverse the process, transmitting

    external signals back to the spinal cord.

    A damaged nerve cannot communi-

    cate with the rest o the nervous system

    or transmit signals back and orth as its

    designed to, which impacts a persons abil-

    ity to move and eel.

    Te key to the gel-implant healing pro-

    cess, said Rochkind, is that the implant,

    which is tube-like, creates a bridge that

    encourages the torn cell ends to connect.

    Te gel is derived rom antioxidants,

    synthetic brous protein peptides, and

    hyaluronic acid to prevent drying. Te

    tube was a major actor in the restoration

    process, said Rockind, even in cases with

    massive nerve damage.

    When grown in the gel, cells show

    excellent development as well as intensive

    ber growth, he said. Tis could have

    implications or the treatment o diseasessuch as Parkinsons, or which research-

    ers are actively exploring cell therapy as a

    potential solution.

    Another 2013 study at AU by Pro.

    Illana Gozes, a recent recipient o the

    Meitner-Humboldt Research Award or

    her lielong contribution to brain sciences,

    shows great promise but is urther away

    rom an applied clinical use.

    Gozes, the director o AUs Adams

    Super Center or Brain Studies, who holds

    the Lily and Avraham Gildor chair or the

    investigation o growth actors, with her

    research team developed davunetide, or

    NAP, a peptide compound that heals

    microscopic tube-like units ound inside

    brain cells called microtubule networks.

    Te compounds ultimately transmit

    important proteins that allow the cells to

    communicate. Tis is the kind o commu-

    nication that ails in diseases like Parkin-

    sons and Alzheimers.

    Te experiment, using two groups o

    animal subjects, ound that one injection

    o NAP could preserve and revive dam-

    aged microtubule networks.

    Both the mouse group that was gene

    ically produced to have the nerve ce

    damage and the group in which it w

    induced by the use o an injected su

    stance showed retarded cell damage

    restored nerve cell unction.In both control groups o mice that d

    not receive the NAP, each continued

    experience nerve cell decline.

    Te study was published in the journ

    Neurobiology o Disease.

    Gozes said that uture research mig

    discover which patients would benet th

    most rom the therapy by developing

    better clinical application.

    Earlier research with NAP indicat

    that patients with low cognitive unctio

    scores, which are usually an indication

    a developing case o Alzheimers diseas

    improved with the use o NAP.

    In addition, earlier studies were show

    to improve the damaged microtubule ne

    works o patients diagnosed with schiz


    l Jtnw p

    ju J s


    z p f hu

    c r c.

    israel:t y


  • 7/27/2019 JTNews | October 13, 2013


    friday, october 11, 2013 nwww.jtnews.net n jtnws

    inside this issue


    get Jtnews in your inbox!Every weekday at 3 p.m. Just visit www.jtnews.net,

    scroll down, and fll out the short orm to sign up.

    p u b l i sh e d by j e w i s h t r a n s c r ip t m ed i a


    A Proud Partner Agency o

    JTNews is the Voice of Jewish Washington. Our

    mission is to meet the interests of our Jewish

    community through fair and accurate coverage of

    local, national and international news, opinion and

    information. We seek to expose our readers to di-

    verse viewpoints and vibrant debate on many fronts,

    including the news and events in Israel. We strive

    to contribute to the continued growth of our local

    Jewish community as we carry out our mission.

    2041 Third Avenue, Seattle, WA 98121206-441-4553 editor@jtnews.net


    JTNews (ISSN0021-678X) is published biweekly by

    The Seattle Jewish Transcript, a nonproft corporation

    owned by the Jewish Federation o Greater Seattle,

    2041 3rd Ave., Seattle, WA 98121. Subscriptions are

    $56.50 or one year, $96.50 or two years. Periodicals

    postage paid at Seattle, WA. POSTMASTER: Send

    address changes to JTNews, 2041 Third Ave., Seattle,

    WA 98121.

    Reach us directly at 206-441-4553 + ext.

    Publisher & Editor *Joel Magalnick 233

    Associate Editor Emily K. Alhadeff 240

    Sales Manager Lynn Feldhammer 264

    Account Executive David Stahl

    Classifeds Manager Rebecca Minsky 238Art Director Susan Beardsley 239

    Intern Esther Goldberg

    Board of directors

    Chuck Stempler, Chair*; Jerry Anches; Lisa Brashem;

    Nancy Greer; Cynthia Flash Hemphill*; Ron Leibsohn;

    Stan Mark; Cantor David Serkin-Poole*

    Keith Dvorchik, CEO and President,

    Jewish Federation o Greater Seattle

    Celie Brown, Federation Board Chair

    *Member, JTNews Editorial BoardEx-Ofcio Member

    RemembeR when




    c p

    o 25

    welcome, ne advertisers! Barrie Anne Photography

    UW Robinson Center for Young Scholars

    Tell them you saw them in JTNews!

    does something look diffeRent?

    You may have noticed on the ront cover that weve done a little design reresh in

    this issue o JNews. But the changes go deeper. Weve reorganized the order o some

    eatures to make them more consistent and easier to nd.

    In addition, we are also debuting our special sections this month two in thisissue and two in the next. J-een, the teen section we have run a couple times a year,

    now goes monthly. Tat starts on page 14. On page 25 you will nd the premiere

    o Northwest Jewish Seniors, which will provide advice, events listings and more.

    Coming later this month will be an expansion o our popular Northwest Jewish Family

    magazine and articles rom our Jew-ish.com young adults website. Enjoy!

    G ov yov

    Rabbi Donniel Hartman muses on the newly released Pew Research Center o U.S. Jews and says that onc

    we get past our own biases in the results, we can nd some important nuggets about our Jewish uture.

    jw g, g y Our two largest community supplementary high school programs have been expanding their ootprints an

    programs in interesting and diverse ways.

    Fo oy good ow

    Hillel at the University o Washington has a new member on sta a liaison between Israelis and Jewish


    i d g

    A recent Hadassah event at a local art gallery seeks to show that the womens organization can be releva

    to women